Abstract
Prion diseases are fatal neurodegenerative zoonotic foodborne disorders, which are caused by an abnormal isoform of prion protein (PrPSc) derived from the cellular isoform of prion protein (PrPC). According to epidemiological surveillance and in vivo experiments, exposure to the PrPSc during the weaning period is fraught with risk, suggesting that, during development, the intestinal defenses and the immune system are involved in PrPSc infection susceptibility. Although it remains unclear how PrPSc passes through the natural biological barriers during its invasion of intestinal cells, the 37 kDa/67 kDa laminin receptor is suspected to be one of the receptors involved in PrPSc-incorporation. In addition, we have recently shown that the neonatal Fc receptor (nFcR), which contributes to the uptake of maternal antibodies into the intestine, may play an important role in PrPSc incorporation. In this review, recent studies on PrPSc uptake and models of PrPSc incorporation into the intestine via the laminin and Fc receptors are described.
Keywords: Prion disease, PrPSc uptake, Fc receptor, neurodegenerative diseases, follicular dendritic cells, immunoglobulins, epithelial barriers, immunohistochemistry, laminin receptor precursors
Mini-Reviews in Organic Chemistry
Title: Penetration of Infectious Prion Protein in the Intestine During the Lactation Period
Volume: 9 Issue: 1
Author(s): Ryuta Uraki, Akikazu Sakudo, Yasuhisa Ano, Juri Kono, Masayoshi Yukawa, Gianluigi Zanusso, Antonio Toniolo and Takashi Onodera
Affiliation:
Keywords: Prion disease, PrPSc uptake, Fc receptor, neurodegenerative diseases, follicular dendritic cells, immunoglobulins, epithelial barriers, immunohistochemistry, laminin receptor precursors
Abstract: Prion diseases are fatal neurodegenerative zoonotic foodborne disorders, which are caused by an abnormal isoform of prion protein (PrPSc) derived from the cellular isoform of prion protein (PrPC). According to epidemiological surveillance and in vivo experiments, exposure to the PrPSc during the weaning period is fraught with risk, suggesting that, during development, the intestinal defenses and the immune system are involved in PrPSc infection susceptibility. Although it remains unclear how PrPSc passes through the natural biological barriers during its invasion of intestinal cells, the 37 kDa/67 kDa laminin receptor is suspected to be one of the receptors involved in PrPSc-incorporation. In addition, we have recently shown that the neonatal Fc receptor (nFcR), which contributes to the uptake of maternal antibodies into the intestine, may play an important role in PrPSc incorporation. In this review, recent studies on PrPSc uptake and models of PrPSc incorporation into the intestine via the laminin and Fc receptors are described.
Export Options
About this article
Cite this article as:
Uraki Ryuta, Sakudo Akikazu, Ano Yasuhisa, Kono Juri, Yukawa Masayoshi, Zanusso Gianluigi, Toniolo Antonio and Onodera Takashi, Penetration of Infectious Prion Protein in the Intestine During the Lactation Period, Mini-Reviews in Organic Chemistry 2012; 9 (1) . https://dx.doi.org/10.2174/157019312799079947
DOI https://dx.doi.org/10.2174/157019312799079947 |
Print ISSN 1570-193X |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6298 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Nucleic Acids Delivery Systems: A Challenge for Pharmaceutical Technologists
Current Drug Metabolism HIV-1 Vectors: Fulfillment of Expectations, Further Advancements, and Still A Way To Go
Current HIV Research Prion Disease: Chemotherapeutic Strategies
Infectious Disorders - Drug Targets Antidepressants and Neuroinflammation: Can Antidepressants Calm Glial Rage Down?
Mini-Reviews in Medicinal Chemistry GPCR Binding Technologies: An Overview
Current Topics in Medicinal Chemistry Concentration-Dependent Bimodal Effect of Specific 18 kDa Translocator Protein (TSPO) Ligands on Cell Death Processes Induced by Ammonium Chloride: Potential Implications for Neuropathological Effects Due to Hyperammonemia
CNS & Neurological Disorders - Drug Targets The First Years of Linezolid Experience in Clinical Practice: A Balance and Future Implications
Anti-Infective Agents in Medicinal Chemistry Management of Glioblastoma Multiforme by Phytochemicals: Applications of Nanoparticle-Based Targeted Drug Delivery System
Current Drug Targets Role of Nitric Oxide and Reactive Oxygen Species in Arthritis
Current Pharmaceutical Design Survivin Modulators: An Updated Patent Review (2011 - 2015)
Recent Patents on Anti-Cancer Drug Discovery Antimicrobial Peptide Delivery Strategies: Use of Recombinant Antimicrobial Peptides in Paratransgenic Control Systems
Current Drug Targets Immunomodulatory Activity of Mesenchymal Stem Cells
Current Stem Cell Research & Therapy Editorial (Thematic Issue: Managing Strategies for Diverse Diseases: Challenges from Bench to Bedside Translation in Successful Drug Discovery and Development)
Current Pharmaceutical Design Combinatorial Chemistry on Solid Support in the Search for Central Nervous System Agents
Combinatorial Chemistry & High Throughput Screening Immune Cell Entry to Central Nervous System - Current Understanding and Prospective Therapeutic Targets
Endocrine, Metabolic & Immune Disorders - Drug Targets New Approach to Immunotherapy Against Organ-specific Autoimmune Diseases with T Cell Receptor and Chemokine Receptor DNA Vaccines
Current Drug Targets - Immune, Endocrine & Metabolic Disorders Targeted Drugs and Nanomedicine: Present and Future
Current Pharmaceutical Design Cannabis-Derived Substances in Cancer Therapy – An Emerging Anti- Inflammatory Role for the Cannabinoids
Current Clinical Pharmacology <i>In Vivo/Ex Vivo</i> EPR Investigation of the Brain Redox Status and Blood-Brain Barrier Integrity in the 5xFAD Mouse Model of Alzheimer's Disease
Current Alzheimer Research The NMDA Receptor as a Therapeutic Target in Major Depressive Disorder
CNS & Neurological Disorders - Drug Targets